Clinical manifestations of active tuberculosis patients coinfected with severe acute respiratory syndrome coronavirus-2.

ABSTRACT:

Summary background

The coronavirus 2019 pandemic was caused by a new single-strand RNA virus that originated from Wuhan, China, and infected more than 190 countries. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) coinfection with tuberculosis posed a serious public health concern and complicated the prognosis and treatment of patients. Since both are respiratory diseases, the sign and symptoms may overlap and could have synergistic effects on the host that can increase mortality during coinfection. The present investigation reported the clinical characteristics of patients having coinfection of COVID-19 and tuberculosis (COVID-TB).

Methods

We performed a retrospective investigation on COVID-19 infection in tuberculosis patients between the years 2020 and 20

SUBMITTER: Habib G 

PROVIDER: S-EPMC9985913 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature